Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-25-162672
Filing Date
2025-07-22
Accepted
2025-07-22 17:17:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d71497dsc14d9a.htm SC 14D9/A 15105
  Complete submission text file 0001193125-25-162672.txt   16786
Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Filed by) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Subject) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-92605 | Film No.: 251141048
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)